mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.02 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |